Skip to content

Pharmacy

Amneal gets U.S. FDA approval for calcium gluconate injection

Amneal gets U.S. FDA approval for calcium gluconate injection

Amneal Pharmaceuticals has received Abbreviated New Drug Application (“ANDA”) approval from the U.S. Food and Drug Administration (“FDA”) for calcium gluconate in sodium chloride injection, 1000 mg/50 mL and 2000 mg/100 mL. This injectable product is currently on the U.S. FDA shortage product list.

CDC acts on NACDS’ concerns, removes RSV vax barrier

CDC acts on NACDS’ concerns, removes RSV vax barrier

Following timely outreach from NACDS on behalf of the industry, NACDS was pleased to see efficient action from the Centers for Disease Control and Prevention (CDC) and Centers for Medicare & Medicare Services (CMS) to help mitigate RSV (Respiratory Syncytial Virus) vaccine access challenges at pharm

AmerisourceBergen becomes Cencora

AmerisourceBergen becomes Cencora

Cencora, Inc. today announced the completion of its name and stock ticker change from AmerisourceBergen Corporation, marking the latest stage of the company’s evolution as a leader in global pharmaceutical services.